Evidence map›Paper›PMID 35027428›Full record

ArticleBMJ open respiratory research2022

Impact of COVID-19 on people with asthma: a mixed methods analysis from a UK wide survey.

Keir Elmslie James Philip, Sara Buttery, Parris Williams, Bavithra Vijayakumar, James Tonkin, Andrew Cumella, Lottie Renwick, Lizzie Ogden, Jennifer K Quint, Sebastian L Johnston and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMJ open respiratory research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
9.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 74 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Telemedicine Use Among Adults with Asthma in the United States, 2021-2022.Telemedicine journal and e-health : the official journal of the American Telemedicine Association · 2024
    Article
  15. Bronchial Asthma and COVID-19: Etiology, Pathological Triggers, and Therapeutic Considerations.Pathophysiology : the official journal of the International Society for Pathophysiology · 2024
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 4 countries.

Keir Elmslie James PhilipNational Heart and Lung Institute, Imperial College London, London, UK k.philip@imperial.ac.uk.ORCID 0000-0001-9614-3580
Sara ButteryNational Heart and Lung Institute, Imperial College London, London, UK.
Parris WilliamsNational Heart and Lung Institute, Imperial College London, London, UK.
Bavithra VijayakumarNational Heart and Lung Institute, Imperial College London, London, UK.
James TonkinNational Heart and Lung Institute, Imperial College London, London, UK.
Andrew CumellaAsthma UK and British Lung Foundation Partnership, London, UK.
Lottie RenwickPolicy and External Affairs, Asthma UK, London, UK.
Lizzie OgdenAsthma UK and British Lung Foundation Partnership, London, UK.
Jennifer K QuintNational Heart and Lung Institute, Imperial College London, London, UK.
Sebastian L JohnstonNational Heart and Lung Institute, Imperial College London, London, UK.
Michael I PolkeyNational Heart and Lung Institute, Imperial College London, London, UK.
Nicholas S HopkinsonNational Heart and Lung Institute, Imperial College London, London, UK.ORCID 0000-0003-3235-0454
Harefield Hospital · GBBritish Lung Foundation · GBAsthma UK · GBLung Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe impact of acute COVID-19 on people with asthma appears complex, being moderated by multiple interacting disease-specific, demographic and environmental factors. Research regarding longer-term effects in this group is limited. We aimed to assess impacts of COVID-19 and predictors of persistent symptoms, in people with asthma.

methodsUsing data from an online UK-wide survey of 4500 people with asthma (median age 50-59 years, 81% female), conducted in October 2020, we undertook a mixed methods analysis of the characteristics and experience of those reporting having had COVID-19.

resultsThe COVID-19 group (n=471, 10.5%) reported increased inhaler use and worse asthma management, compared with those not reporting COVID-19, but did not differ by gender, ethnicity or household income. Among the COVID-19 group, 56.1% reported having long COVID, 20.2% were 'unsure'. Those with long COVID were more likely than those without long COVID to describe: their breathing as worse or much worse after their initial illness (73.7% vs 34.8%, p<0.001), increased inhaler use (67.8% vs 34.8%, p<0.001) and worse or much worse asthma management (59.6% vs 25.6%, p<0.001). Having long COVID was not associated with age, gender, ethnicity, UK nation or household income.Analysis of free text survey responses identified three key themes: (1) variable COVID-19 severity, duration and recovery; (2) symptom overlap and interaction between COVID-19 and asthma; (3) barriers to accessing healthcare.

conclusionsPersisting symptoms are common in people with asthma following COVID-19. Measures are needed to ensure appropriate healthcare access including clinical evaluation and investigation, to distinguish between COVID-19 symptoms and asthma.

Indexed as

AsthmaCOVID-19FemaleHumansMaleMiddle AgedPost-Acute COVID-19 SyndromeSARS-CoV-2United Kingdomasthmaasthma in primary careCOVID-19respiratory infectionviral infection

Identifiers

PMID35027428
PMCPMC8762134
OpenAlexW4226018616

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.